Article
Novel compound heterozygous ACO2 mutations in an infant with progressive encephalopathy: A newly identified neurometabolic syndrome.
Brain & development - 1 Oct 2020
Park Ji Soo, Kim Man Jin, Kim Soo Yeon, Lim Byung Chan, Kim Ki Joong, Seong Moon-Woo, Lee Jin Sook, Chae Jong-Hee
Abstract excerpt
BACKGROUND: The ACO2 gene encodes mitochondrial aconitase, the enzyme involved in the second step of the tricarboxylic acid cycle, catalyzing the interconversion of citrate into isocitrate. To date, fewer than 20 families harboring ACO2 mutations have been identified since the first report of a neurodegenerative disorder such as infantile cerebellar retinal degeneration in 2012. Subsequently, various phenotypes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
